Aller au contenu
Force et musclesArticle de recherche3 min read

Nerve-muscle changes appear in older adults before sarcopenia is diagnosed

Collectif éditorial MoveVitals · Study published · Reading updated

Original paper:Neuromuscular impairment at different stages of human sarcopenia. · Journal of cachexia, sarcopenia and muscle · 2024 · Article original ↗

À retenir

Comparing 42 young adults with 88 older adults (39 non-sarcopenic, 31 pre-sarcopenic, 18 sarcopenic), signs of nerve-muscle junction instability, motor unit loss and nerve damage were found in all older groups, mostly regardless of sarcopenia status. This points to changes that precede diagnosis, but the design is a single cross-sectional comparison in a small sample and cannot show how people progress over time.

Study design

Article de recherche

Reading basis

Published abstract

Reading focus

Design & applicability

Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.

Question de recherche

Muscle loss in older age is thought to involve degeneration of the motor nerve cells, the junction where nerve meets muscle (NMJ) and the loss of motor units (MUs). These features had not been studied together in people across the stages of sarcopenia. The authors compared neuromuscular integrity and function across stages, focusing on NMJ stability and MU properties.

Population et méthode

Cross-sectional study of 42 young individuals (aged 25.98 ± 4.6 years; 57% female) and 88 older individuals (aged 75.9 ± 4.7 years; 55% female). Older participants were screened by the revised European Working Group on Sarcopenia in Older People 2 guidelines. Knee extensor force was measured by isometric dynamometry, muscle morphology by ultrasound and motor unit potentials by intramuscular electromyography (iEMG), with a motor unit number estimate (iMUNE) and blood samples. Muscle biopsies came from a subgroup of 16 young and 52 older participants.

Résultats

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    Of the 88 older people, 39 were non-sarcopenic (NS), 31 pre-sarcopenic (PS) and 18 sarcopenic (S). Quadriceps force, cross-sectional area and appendicular lean mass fell gradually across the stages (P < 0.0001 for all).
  2. 2
    Near fibre segment jitter, a sign of impaired transmission at the NMJ, was higher in all older groups than in young people (young vs NS and S: P < 0.0001; young vs PS: P = 0.0169).
  3. 3
    Markers of NMJ instability and nerve damage rose in older groups: C-terminal agrin fragment (P < 0.0001), neural cell adhesion molecule-positive fibres (young vs NS: P < 0.0001; young vs S: P = 0.02) and serum neurofilament light chain (P < 0.0001). Motor unit number estimates were lower in all older groups (P < 0.0001).
  4. 4
    Most motor unit and NMJ measures did not differ between older people with and without sarcopenia.

Limites et incertitude

  1. 1
    People were measured once, so the study cannot show whether non-sarcopenic older adults go on to develop sarcopenia.
  2. 2
    Groups were small, especially sarcopenic participants (18), and muscle biopsies were taken from only a subgroup of 52 older and 16 young participants.
  3. 3
    Age differences between young and older groups mean the nerve-muscle changes are partly a comparison of life stages, not of sarcopenia itself.
  4. 4
    This reading is based on the abstract only.

Mise en perspective

The study suggests that nerve-related changes in muscle begin before an older person meets sarcopenia criteria, which fits advice to build and maintain strength earlier rather than waiting for a diagnosis. It does not show which training prevents these nerve changes, and concerns about weakness or falls should be discussed with a clinician.

Vos données

Intramuscular electromyography and nerve markers are lab measures and cannot be tracked on your own. The closer things you can track are grip strength, chair-stand or walking tests and strength-training logs, compared using the same method over months.

Comprendre ce type de preuve

The index does not establish a precise design. Read the methods before making causal claims; check population, comparator, outcomes and uncertainty in the source.

Résumé structuré des auteurs English

Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.

Background

Degeneration of the motoneuron and neuromuscular junction (NMJ) and loss of motor units (MUs) contribute to age-related muscle wasting and weakness associated with sarcopenia. However, these features have not been comprehensively investigated in humans. This study aimed to compare neuromuscular system integrity and function at different stages of sarcopenia, with a particular focus on NMJ stability and MU properties.

Methods

We recruited 42 young individuals (Y) (aged 25.98 ± 4.6 years; 57% females) and 88 older individuals (aged 75.9 ± 4.7 years; 55% females). The older group underwent a sarcopenia screening according to the revised guidelines of the European Working Group on Sarcopenia in Older People 2. In all groups, knee extensor muscle force was evaluated by isometric dynamometry, muscle morphology by ultrasound and MU potential properties by intramuscular electromyography (iEMG). MU number estimate (iMUNE) and blood samples were obtained. Muscle biopsies were collected in a subgroup of 16 Y and 52 older participants.

Results

Thirty-nine older individuals were non-sarcopenic (NS), 31 pre-sarcopenic (PS) and 18 sarcopenic (S). A gradual decrease in quadriceps force, cross-sectional area and appendicular lean mass was observed across the different stages of sarcopenia (for all P < 0.0001). Handgrip force and the Short Physical Performance Battery score also showed a diminishing trend. iEMG analyses revealed elevated near fibre segment jitter in NS, PS and S compared with Y (Y vs. NS and S: P < 0.0001; Y vs. PS: P = 0.0169), suggestive of age-related impaired NMJ transmission. Increased C-terminal agrin fragment (P < 0.0001) and altered caveolin 3 protein expression were consistent with age-related NMJ instability in all the older groups. The iMUNE was lower in all older groups (P < 0.0001), confirming age-related loss of MUs. An age-related increase in MU potential complexity was also observed. These observations were accompanied by increased muscle denervation and axonal damage, evinced by the increase in neural cell adhesion molecule-positive fibres (Y vs. NS: P < 0.0001; Y vs. S: P = 0.02) and the increase in serum concentration of neurofilament light chain (P < 0.0001), respectively. Notably, most of these MU and NMJ parameters did not differ when comparing older individuals with or without sarcopenia.

Conclusions

Alterations in MU properties, axonal damage, an altered innervation profile and NMJ instability are prominent features of the ageing of the neuromuscular system. These neuromuscular alterations are accompanied by muscle wasting and weakness; however, they appear to precede clinically diagnosed sarcopenia, as they are already detectable in older NS individuals.

Sources et attribution

Neuromuscular impairment at different stages of human sarcopenia.

Sarto F, Franchi MV, McPhee JS, Stashuk DW, Paganini M, Monti E, Rossi M, Sirago G, Zampieri S, Motanova ES, Valli G, Moro T, Paoli A, Bottinelli R, Pellegrino MA, De Vito G, Blau HM, Narici MV.

Journal of cachexia, sarcopenia and muscle · 2024-09-05

DOI: 10.1002/jcsm.13531 ↗PubMed · 39236304 ↗Europe PMC · Licence indiquée: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée

Sources vérifiées 2026-11-01

Guides pratiques

À lire ensemble

·Synthèse de revues

ACSM review of 137 reviews: resistance training works, and few programme details matter

The American College of Sports Medicine pooled 137 systematic reviews (over 30,000 healthy adults) and concluded that resistance training beats no exercise for strength, muscle size, power, endurance and several function tests. Few programme details changed results consistently: heavier loads (80% or more of one-repetition maximum) and 2 to 3 sets favoured strength, and at least 10 sets a week favoured muscle size, while training to failure, exercise type and periodization did not. It summarises reviews rather than new trials, gives no pooled effect sizes, and drew mostly on untrained adults and overlapping source trials.

Medicine & Science in Sports & Exercise

Explications approfondiesLire l’étude →
·Méta-analyse d’essais

Nearly every resistance training plan beat no exercise; heavy loads led for strength

In a network meta-analysis of randomised trials in healthy adults (178 studies and 5097 people for strength, 119 studies and 3364 people for muscle size), nearly all resistance training prescriptions beat no exercise. Higher-load, multiset, thrice-weekly training ranked best for strength (standardised mean difference 1.60, 95% credible interval 1.38 to 1.82) and higher-load, multiset, twice-weekly training for muscle size (0.66, 0.47 to 0.85). Most prescriptions could not be statistically separated from each other (the 95% interval contained zero in 91% of the comparisons between them) and risk of bias was moderate to high, so the rankings are tentative.

British Journal of Sports Medicine

Explications approfondiesLire l’étude →
·Méta-analyse observationnelle

Muscle-strengthening linked to lower risk of death, heart disease, cancer and diabetes

Pooling 16 prospective cohort studies of adults, people who did muscle-strengthening activity had a 15% lower risk of all-cause mortality (RR 0.85, 95% CI 0.79 to 0.93) and a 17% lower risk of both cardiovascular disease and diabetes (RR 0.83 for each) than people who did none. The pooled mortality curve was lowest at about 40 min/week (RR 0.83), but whether larger amounts help or hurt is unclear. All of this is observational, from mostly US self-reported data, and the authors rated the certainty of evidence as very low for most outcomes.

British Journal of Sports Medicine

Explications approfondiesLire l’étude →
·Méta-analyse d’essais

Protein supplements and weight training: small extra gains, smaller in older adults

Pooling 49 randomised trials with 1,863 healthy adults who did resistance training for at least 6 weeks, protein supplements added 0.30 kg of fat-free mass (95% CI 0.09 to 0.52) and 2.49 kg of one-repetition-maximum strength (0.64 to 4.33) on top of training alone. These gains were small next to the effect of training itself, were weaker with older age, and the suggested plateau near 1.6 g/kg/day was not statistically significant (p=0.079). One author has received funding from the US National Dairy Council, which supported trials in the analysis.

British Journal of Sports Medicine

Explications approfondiesLire l’étude →
Force et muscles →